시장보고서

상품코드

1462912

세계 조혈모세포이식(HSCT) 시장 : 이식 유형별, 용도별, 적응증별, 유통 채널별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2024년-2032년)

Hematopoietic Stem Cell Transplantation Market, By Transplant Type, By Application, By Indication, By Distribution Channel, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 04월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 301 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

조혈모세포이식 시장 규모는 2023년 28억 2,312만 달러로 평가되었고 2024년부터 2032년까지 복합 연간 성장률(CAGR) 10.7%로 확대될 전망입니다.

조혈모세포이식 시장 - 시장 역학

백혈병과 림프종 환자 증가는 시장 수요를 촉진

조혈모세포이식 시장은 백혈병과 림프종의 이환율이 증가함에 따라 더욱 빠르게 확대될 것으로 예상됩니다. 미국에서는 백혈병, 림프종, 골수종의 진단이 176,200회, 림프성 백혈병과 골수종의 생존이 1,399,180례인 것이 백혈병 림프종 협회의 2019년 보고서에서 밝혀졌습니다. 조혈모세포이식(HSCT) 시장은 이환율 증가로 확대될 것으로 예상됩니다.

조혈모세포이식 시장 - 주요 인사이트력

우리의 리서치 애널리스트가 공유한 분석에 따르면 시장은 예측 기간(2024년-2032년)에 약 10.7%의 복합 연간 성장률(CAGR)로 매년 성장할 것으로 예측됩니다.

이식 유형별로 자기 이식 부문이 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예측됩니다.

용도별로는 골수 줄기세포 이식이 예측 기간 동안 큰 시장 점유율을 차지할 전망입니다.

지역별로는 북미가 2023년 매출에서 최고입니다.

조혈모세포이식 시장 - 세분화 분석 :

세계 조혈모세포이식 시장은 이식 유형 응용, 적응증, 최종 사용자, 치료 영역, 지역에 따라 부문화됩니다.

이식 유형에서 조혈모세포이식 시장은 자기 이식, 동종 이식 등으로 구분됩니다. 기술의 진보, 혈액 질환의 유병률 증가, 줄기세포 치료의 응용 확대로 예측 기간 동안 자기 이식 분야가 최대 시장 점유율을 차지할 것으로 예상됩니다.

조혈모세포이식 산업은 애플리케이션에서 제대 줄기 세포 이식, 골수 줄기 세포 이식, 말초 줄기 세포 이식 등으로 이분됩니다. 골수 줄기 세포 이식 분야는 예측 기간 동안 큰 시장 점유율을 차지할 것으로 예상됩니다. 골수 줄기 세포 이식의 주요 적응증에는 골수에 영향을 미치는 비악성 질환과 다양한 혈액 악성 종양이 포함됩니다. 여기에는 림프종, 골수이형성 증후군, 재생불량성 빈혈, 급성 및 만성 백혈병, 적혈구 생성에 영향을 미치는 특정 유전성 질환 등이 포함됩니다.

적응증에서 시장은 백혈병, 림프 증식 성 질환, 비 악성 질환 등으로 이분됩니다.

유통 채널별로 오프라인과 온라인으로 이분됩니다.

최종 사용자를 기반으로 조혈모세포이식 시장은 소매 약국, 병원 약국 및 전문 클리닉으로 이분됩니다.

조혈모세포이식 시장 - 지리적 인사이트

지리적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 의해 더 나뉩니다. 예측 기간 동안 북미가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 북미 시장은 주로 백혈병 환자 수 증가와 연구 개발에 있어서의 정부,민간 부문의 지출 증가 등의 요인에 의해 견인되고 있습니다. 예를 들어 캐나다암협회가 2022년 5월 발표한 통계에 따르면 2022년 6,700명의 캐나다인이 백혈병 진단을 받을 것으로 예측되고 있습니다. 게다가 2,700명의 여성이 백혈병 진단을 받았고, 그 중 1,300명이 사망하고 4,000명의 남성이 백혈병 진단을 받을 것이라고 말했습니다.

조혈모세포이식 시장 - 경쟁 구도 :

시장의 주요 기업은 Pfizer Inc., Akari Therapeutics, Plc, Otsuka America Pharmaceutical, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Lonza, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Sanofi, FUJ Corporation, bluebird bio, Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Kiadis Pharma, Taiga Biotechnologies, Inc., CellGenix GmbH, Escape Therapeutics, Inc., Marker Therapeutics, Inc. and Talaris Therapeutics.

소개
북미
- 개요
- 북미 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 - 조혈모세포이식 업계

경쟁 대시보드
기업 프로파일
- Pfizer Inc.
- Akari Therapeutics, Plc
- Otsuka America Pharmaceutical, Inc.
- Merck KGaA
- Takeda Pharmaceutical Company Limited
- Lonza
- GlaxoSmithKline plc
- Novartis AG
- Merck &Co., Inc.
- Sanofi
- FUJIFILM Holdings Corporation
- bluebird bio, Inc.
- Pluristem Therapeutics Inc.
- Regen Biopharma Inc.
- Kiadis Pharma
- Taiga Biotechnologies, Inc.
- CellGenix GmbH
- Escape Therapeutics, Inc.
- Talaris Therapeutics
- Marker Therapeutics, Inc.

제14장 애널리스트의 전방위 전망

BJH 24.05.23

REPORT HIGHLIGHT

Hematopoietic Stem Cell Transplantation Market size was valued at USD 2,823.12 Million in 2023, expanding at a CAGR of 10.7% from 2024 to 2032.

Many cancer forms and other illnesses can be treated with hematopoietic stem cell transplantation (HSCT). Two different sources of stem cells are bone marrow and blood. Hematopoietic stem cells are the young, immature blood cells found in bone marrow. The proportion of these blood cells that mature in the bone marrow and enter the bloodstream is quite low. The cells that reach the bloodstream are known as peripheral blood stem cells. After chemotherapy or radiation therapy, healthy hematopoietic stem cells are transplanted to replace absent, sick, or damaged hematopoietic stem cells.

Hematopoietic Stem Cell Transplantation Market- Market Dynamics

Increasing cases of leukemia and lymphoma to propel market demand

The market for hematopoietic stem cell transplantation is predicted to rise more rapidly due to the increased incidence of leukemia and lymphoma. In the United States, leukemia, lymphoma, or myeloma diagnosed 176,200 times, and lymph leukemia and myeloma survived in 1,399,180 cases, according to the Leukemia and Lymphoma Society's 2019 report. The market for hematopoietic stem cell transplantation (HSCT) is expected to grow as a result of the increasing incidence rate.

Hematopoietic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.7% over the forecast period (2024-2032)

Based on transplant type segmentation, the Autologous segment is expected to hold the largest market share over the forecast period

Based on application segmentation, the Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period

Based on region, North America was the leading revenue generator in 2023

Hematopoietic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Hematopoietic Stem Cell Transplantation Market is segmented based on Transplant Type Application, Indication, End User, Therapeutic Area, and Region.

Based on the transplant type, the Hematopoietic Stem Cell Transplantation market is segmented into Autologous, Allogeneic and Others. The Autologous segment is expected to hold the largest market share over the forecast period due to advancements in technology, increased prevalence of hematological disorders, and expanding applications of stem cell therapies.

Based on the application, the Hematopoietic Stem Cell Transplantation industry is bifurcated into Cord Stem Cell Transplant, Bone Marrow Stem Cell Transplant, Peripheral Stem Cell Transplant and Others. The Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period. The main indications for bone marrow stem cell transplantation include non-malignant bone marrow-affecting diseases and a variety of hematological malignancies. These could include lymphomas, myelodysplastic syndromes, aplastic anemia, acute and chronic leukemias, and specific hereditary illnesses that impact the generation of red blood cells.

Based on the indication, the market is bifurcated into Leukemia, Lymphoproliferative Disorders, Non-Malignant Disorders and Others.

Based on the distribution channel, the industry is bifurcated into Offline and Online.

Based on the end user, the Hematopoietic Stem Cell Transplantation market is bifurcated into Retail Pharmacy, Hospital Pharmacy and Specialty Clinics.

Hematopoietic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share over the forecast period. The market in the North American area is primarily driven by factors such as the rising number of leukemia patients and increased governmental and private sector expenditure in research and development. For instance, statistics released in May 2022 by the Canadian Cancer Society indicates that 6,700 Canadians are anticipated to receive a leukemia diagnosis year 2022. Additionally, it stated that 2,700 women will receive a leukemia diagnosis, 1,300 of them will pass away, and 4,000 males will receive a leukemia diagnosis.

Hematopoietic Stem Cell Transplantation Market- Competitive Landscape:

The key players in the market are Pfizer Inc., Akari Therapeutics, Plc, Otsuka America Pharmaceutical, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Lonza, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Sanofi, FUJIFILM Holdings Corporation, bluebird bio, Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Kiadis Pharma, Taiga Biotechnologies, Inc., CellGenix GmbH, Escape Therapeutics, Inc., Marker Therapeutics, Inc. and Talaris Therapeutics.

Recent Developments:

In May 2022, Priothera was granted approval by the US Food and Drug Administration to begin a Phase 2b/3 research using mocravimod in patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.

Akari Therapeutics, Plc

Otsuka America Pharmaceutical, Inc.

Merck KGaA

Takeda Pharmaceutical Company Limited

Lonza

GlaxoSmithKline plc

Novartis AG

Merck & Co., Inc.

Sanofi

FUJIFILM Holdings Corporation

bluebird bio, Inc.

Pluristem Therapeutics Inc.

Regen Biopharma Inc.

Kiadis Pharma

Taiga Biotechnologies, Inc.

CellGenix GmbH

Escape Therapeutics, Inc.

Talaris Therapeutics

Marker Therapeutics, Inc.

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE- MARKET ANALYSIS, 2019 - 2032

Autologous
Allogeneic
Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cord Stem Cell Transplant
Bone Marrow Stem Cell Transplant
Peripheral Stem Cell Transplant
Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

Leukemia
Lymphoproliferative Disorders
Non-Malignant Disorders
Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

Offline
Online

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Retail Pharmacy
Hospital Pharmacy
Specialty Clinics

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Hematopoietic Stem Cell Transplantation Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Hematopoietic Stem Cell Transplantation Market Snippet by Transplant Type
- 2.1.2.Hematopoietic Stem Cell Transplantation Market Snippet by Application
- 2.1.3.Hematopoietic Stem Cell Transplantation Market Snippet by Indication
- 2.1.4.Hematopoietic Stem Cell Transplantation Market Snippet by Distribution Channel
- 2.1.5.Hematopoietic Stem Cell Transplantation Market Snippet by End User
- 2.1.6.Hematopoietic Stem Cell Transplantation Market Snippet by Country
- 2.1.7.Hematopoietic Stem Cell Transplantation Market Snippet by Region
2.2.Competitive Insights

3.Hematopoietic Stem Cell Transplantation Key Market Trends

3.1.Hematopoietic Stem Cell Transplantation Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Hematopoietic Stem Cell Transplantation Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Hematopoietic Stem Cell Transplantation Market Opportunities
3.4.Hematopoietic Stem Cell Transplantation Market Future Trends

4.Hematopoietic Stem Cell Transplantation Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Hematopoietic Stem Cell Transplantation Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Hematopoietic Stem Cell Transplantation Market Landscape

6.1.Hematopoietic Stem Cell Transplantation Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Hematopoietic Stem Cell Transplantation Market - By Transplant Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Transplant Type, 2023 & 2032 (%)
- 7.1.2.Autologous
- 7.1.3.Allogeneic
- 7.1.4.Others

8.Hematopoietic Stem Cell Transplantation Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Cord Stem Cell Transplant
- 8.1.3.Bone Marrow Stem Cell Transplant
- 8.1.4.Peripheral Stem Cell Transplant
- 8.1.5.Others

9.Hematopoietic Stem Cell Transplantation Market - By Indication

9.1.Overview
- 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 9.1.2.Leukemia
- 9.1.3.Lymphoproliferative Disorders
- 9.1.4.Non-Malignant Disorders
- 9.1.5.Others

10.Hematopoietic Stem Cell Transplantation Market - By Distribution Channel

10.1.Overview
- 10.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 10.1.2.Offline
- 10.1.3.Online

11.Hematopoietic Stem Cell Transplantation Market - By End User

11.1.Overview
- 11.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
- 11.1.2.Retail Pharmacy
- 11.1.3.Hospital Pharmacy
- 11.1.4.Specialty Clinics

12.Hematopoietic Stem Cell Transplantation Market- By Geography

12.1.Introduction
- 12.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2.North America
- 12.2.1.Overview
- 12.2.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in North America
- 12.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4.North America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
- 12.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 12.2.7.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.2.8.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9.U.S.
  - 12.2.9.1.Overview
  - 12.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3.U.S. Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.2.9.6.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.2.9.7.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10.Canada
  - 12.2.10.1.Overview
  - 12.2.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3.Canada Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.2.10.6.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.2.10.7.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.Europe
- 12.3.1.Overview
- 12.3.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Europe
- 12.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4.Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
- 12.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 12.3.7.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.8.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9.Germany
  - 12.3.9.1.Overview
  - 12.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3.Germany Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.9.6.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.9.7.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10.Italy
  - 12.3.10.1.Overview
  - 12.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3.Italy Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.10.6.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.10.7.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11.United Kingdom
  - 12.3.11.1.Overview
  - 12.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3.United Kingdom Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.11.6.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.11.7.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12.France
  - 12.3.12.1.Overview
  - 12.3.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3.France Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.12.6.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.12.7.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13.Russia
  - 12.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2.Russia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.13.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.13.5.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.13.6.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14.Netherlands
  - 12.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2.Netherlands Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.14.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.14.5.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.14.6.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15.Sweden
  - 12.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2.Sweden Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.15.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.15.5.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.15.6.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16.Poland
  - 12.3.16.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2.Poland Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.16.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.16.5.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.16.6.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17.Rest of Europe
  - 12.3.17.1.Overview
  - 12.3.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3.Rest of the Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.3.17.6.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.3.17.7.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.Asia Pacific (APAC)
- 12.4.1.Overview
- 12.4.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Asia Pacific
- 12.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4.Asia Pacific Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
- 12.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 12.4.7.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.8.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9.India
  - 12.4.9.1.Overview
  - 12.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3.India Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.9.6.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.9.7.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10.China
  - 12.4.10.1.Overview
  - 12.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3.China Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.10.6.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.10.7.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11.Japan
  - 12.4.11.1.Overview
  - 12.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3.Japan Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.11.6.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.11.7.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12.South Korea
  - 12.4.12.1.Overview
  - 12.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3.South Korea Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.12.6.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.12.7.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13.Australia
  - 12.4.13.1.Overview
  - 12.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3.Australia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.13.6.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.13.7.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14.Thailand
  - 12.4.14.1.Overview
  - 12.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3.Thailand Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.14.6.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.14.7.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15.Indonesia
  - 12.4.15.1.Overview
  - 12.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3.Indonesia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.15.6.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.15.7.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16.Philippines
  - 12.4.16.1.Overview
  - 12.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3.Philippines Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.16.6.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.16.7.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17.Rest of APAC
  - 12.4.17.1.Overview
  - 12.4.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3.Rest of APAC Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.4.17.6.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.4.17.7.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.Latin America
- 12.5.1.Overview
- 12.5.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Latin America
- 12.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4.Latin America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
- 12.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 12.5.7.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.8.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9.Brazil
  - 12.5.9.1.Overview
  - 12.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3.Brazil Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.5.9.6.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.5.9.7.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10.Mexico
  - 12.5.10.1.Overview
  - 12.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3.Mexico Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.5.10.6.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.5.10.7.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11.Argentina
  - 12.5.11.1.Overview
  - 12.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3.Argentina Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.5.11.6.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.5.11.7.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12.Colombia
  - 12.5.12.1.Overview
  - 12.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3.Colombia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.5.12.6.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.5.12.7.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13.Rest of LATAM
  - 12.5.13.1.Overview
  - 12.5.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3.Rest of LATAM Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.5.13.6.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.5.13.7.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.Middle East and Africa
- 12.6.1.Overview
- 12.6.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
- 12.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4.Middle East and Africa Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
- 12.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 12.6.7.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.8.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9.Saudi Arabia
  - 12.6.9.1.Overview
  - 12.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3.Saudi Arabia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.6.9.6.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.6.9.7.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10.United Arab Emirates
  - 12.6.10.1.Overview
  - 12.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3.United Arab Emirates Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.6.10.6.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.6.10.7.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11.Israel
  - 12.6.11.1.Overview
  - 12.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3.Israel Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.6.11.6.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.6.11.7.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12.Turkey
  - 12.6.12.1.Overview
  - 12.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3.Turkey Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.6.12.6.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.6.12.7.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13.Algeria
  - 12.6.13.1.Overview
  - 12.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3.Algeria Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.6.13.6.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.6.13.7.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14.Egypt
  - 12.6.14.1.Overview
  - 12.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3.Egypt Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.6.14.6.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.6.14.7.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15.Rest of MEA
  - 12.6.15.1.Overview
  - 12.6.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3.Rest of MEA Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 12.6.15.6.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 12.6.15.7.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13.Key Vendor Analysis- Hematopoietic Stem Cell Transplantation Industry

13.1.Competitive Dashboard
13.2.Company Profiles
- 13.2.1.Pfizer Inc.
- 13.2.2.Akari Therapeutics, Plc
- 13.2.3.Otsuka America Pharmaceutical, Inc.
- 13.2.4.Merck KGaA
- 13.2.5.Takeda Pharmaceutical Company Limited
- 13.2.6.Lonza
- 13.2.7.GlaxoSmithKline plc
- 13.2.8.Novartis AG
- 13.2.9.Merck & Co., Inc.
- 13.2.10.Sanofi
- 13.2.11.FUJIFILM Holdings Corporation
- 13.2.12.bluebird bio, Inc.
- 13.2.13.Pluristem Therapeutics Inc.
- 13.2.14.Regen Biopharma Inc.
- 13.2.15.Kiadis Pharma
- 13.2.16.Taiga Biotechnologies, Inc.
- 13.2.17.CellGenix GmbH
- 13.2.18.Escape Therapeutics, Inc.
- 13.2.19.Talaris Therapeutics
- 13.2.20.Marker Therapeutics, Inc.

14.360 Degree Analyst View

15.Appendix

15.1.Research Applicationology
15.2.References
15.3.Abbreviations
15.4.Disclaimer
15.5.Contact Usq